MDRX INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of a Class Action Lawsuit and Upcoming Deadline
09 déc. 2023 08h02 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc.
LIVEPERSON, INC. INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies LivePerson Investors of a Class Action Lawsuit and Upcoming Deadline
08 déc. 2023 14h30 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors who purchased or otherwise acquired LivePerson, Inc.
VERADIGM SHAREHOLDER UPDATE: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of Upcoming Deadline
08 déc. 2023 14h20 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc.
CHPT Investor Alert: Kaplan Fox & Kilsheimer LLP Notifies ChargePoint Investors of a Class Action Lawsuit and Upcoming Deadline
07 déc. 2023 08h00 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired ChargePoint Holdings, Inc.
EGRX Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX)
07 déc. 2023 08h00 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Eagle Pharmaceuticals, Inc.
SLRN Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Acelyrin, Inc. (Nasdaq: SLRN)
07 déc. 2023 08h00 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Acelyrin, Inc.
VERADIGM INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Veradigm Investors of a Class Action Lawsuit and Upcoming Deadline
05 déc. 2023 21h54 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc. (“Veradigm”...
FISKER INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Fisker Investors of a Class Action Lawsuit and Upcoming Deadline
05 déc. 2023 21h51 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired the...
Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX)
04 déc. 2023 08h00 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox is investigating potential claims on behalf of investors who purchased securities of Woodcliff Lake, New Jersey-based Eagle Pharmaceuticals, Inc
Kaplan Fox & Kilsheimer LLP Investigates Acelyrin, Inc. (Nasdaq: SLRN)
04 déc. 2023 08h00 HE
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Acelyrin, Inc.